Known Medicine is a pioneering startup focused on revolutionizing cancer treatment. The company operates in the healthcare and biotechnology market, specifically targeting oncologists—doctors who specialize in treating cancer. Known Medicine aims to address the critical need for personalized cancer treatment by leveraging advanced bioengineering and artificial intelligence (AI).

The core of Known Medicine's business is its custom organoid platform. Organoids are tiny, simplified versions of organs grown in the lab from a patient's cells. These organoids are used to test various cancer treatments to see which one works best for the individual patient. This approach helps oncologists make more informed decisions, potentially increasing the effectiveness of cancer treatments and reducing the time it takes to find the right therapy.

Known Medicine's business model is primarily B2B (business-to-business). They provide their organoid testing services directly to oncology clinics, hospitals, and research institutions. By offering a subscription-based service or per-test pricing, the company generates revenue from healthcare providers who are looking to improve treatment outcomes for their patients.

In summary, Known Medicine is at the forefront of personalized cancer treatment, combining cutting-edge biology research with the latest AI techniques to help oncologists find the best treatment options faster. Their innovative approach not only aims to improve patient outcomes but also to streamline the decision-making process for healthcare providers.

Keywords: personalized cancer treatment, organoid platform, bioengineering, artificial intelligence, oncology, healthcare, biotechnology, patient-specific therapy, cancer research, medical innovation.